|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Reata Pharmaceuticals (NASDAQ: RETA) through any online brokerage.
The latest price target for Reata Pharmaceuticals (NASDAQ: RETA) was reported by Goldman Sachs on May 24, 2021. The analyst firm set a price target for 236.00 expecting RETA to rise to within 12 months (a possible 71.01% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Reata Pharmaceuticals (NASDAQ: RETA) is $138 last updated Fri Jun 18 2021 20:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Reata Pharmaceuticals.
There is no upcoming split for Reata Pharmaceuticals.
Reata Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.